We are pleased to announce the successful completion of UI Pharmaceuticals site registration in South Korea for manufacturing a gel formulation used as antineoplastic drug. This marks an important step in making this treatment available to more patients. This registration underscores our commitment to expanding access to innovative treatments worldwide. UI Pharmaceuticals is proud to be part of the global effort to manufacture and commercialize antineoplastic drug.